.png){kind=icon}
返回期刊详情
Clinical and Molecular Hepatology
IF16.9
论文数966
被引数4160
期刊论文 966
发表时间
.png){kind=icon}
.png){kind=icon}
Network meta-analysis and validation study of expanded liver transplantation criteria for hepatocellular carcinoma: Significant role of alpha-fetoprotein于, D.; 黄, Y.; 朴, J.-S.; 许, S.; 金, S.-O.; 崔, S.H.; 宋, G.-W.; 安, J.; 姜世亨. 肝细胞癌扩大肝移植标准的网络Meta分析与验证研究: 甲胎蛋白的重要作用. 临床分子肝病学. 2026, 32, 751–771. [谷歌学术] [CrossRef].png)
.png)
分享.png)
收藏
PREAI
分享收藏Letter to the editor on Glucagon-like peptide 1 receptoragonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study致编辑的一封信：关于胰高血糖素样肽1受体激动剂和成人2型糖尿病及代谢功能障碍相关脂肪性肝病中肝脏和非肝脏并发症的减少：一项目标试验模拟研究分享收藏
PREAI
分享收藏Beyond diagnostic accuracy: Economic and clinical considerations for NC-MRI in late HCC recurrence surveillance: Letter to the editor on Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography超越诊断准确性：NC-MRI在晚期HCC复发监测中的经济和临床考量：关于“非增强磁共振成像在治愈性治疗后晚期复发肝细胞癌检测中的应用：与增强型计算机断层扫描的前瞻性多中心比较”一文的编者来信分享收藏
PREAI
分享收藏GLP-1RA may open a new era for MASLD treatment: Editorial on Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study胰高血糖素样肽1受体激动剂（GLP-1RA）可能为代谢功能障碍相关脂肪性肝病（MASLD）的治疗开启一个新时代：关于胰高血糖素样肽1受体激动剂和成人2型糖尿病及代谢功能障碍相关脂肪性肝病中肝脏和非肝脏并发症降低的编者按：一项目标试验模拟研究分享收藏
PREAI
分享收藏Correspondence to editorial on Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study致编辑：关于胰高血糖素样肽1受体激动剂和成人2型糖尿病及代谢功能障碍相关脂肪性肝病患者肝脏和非肝脏并发症降低：一项目标试验模拟研究分享收藏
PREAI
分享收藏